to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)
PHASE3
This study is a randomized, double-Blind,international multi-Centre, phase ...
A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
PHASE3
This study is a randomized, double-blind, multi-center, phase III clinical ...
Status
Unknown
Location
Ethics Committeeof cancer hospital, Chinese academy of medical sciences,
Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC
PHASE2
A Randomized, Double-Blind, Multi-Center Phase II Clinical Study to Compare...